Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ethical considerations on pharmacogenomics.

Emilio Mordini1

  • 1Secretary of the Bioethical Commission of the National Research Council Centre for Science, Society and Citizenship, Rome, Italy. e.mordini@bioethics.it

Pharmacological Research
|June 19, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vaccines, Apes, and Conspiracy.

The American journal of bioethics : AJOB·2018
Same author

El Gran Teatro del Mundo.

The American journal of bioethics : AJOB·2018
Same author

The Biodefense Field.

Bioethics·2016
Same author

The Public Sphere in Emerging Infectious Disease Communication: Recipient or Active and Vocal Partner?

Disaster medicine and public health preparedness·2015
Same author

Emerging infectious disease (EID) communication during the 2009 H1N1 influenza outbreak: literature review (2009-2013) of the methodology used for EID communication analysis.

Disaster medicine and public health preparedness·2015
Same author

Considering the human implications of new and emerging technologies in the area of human security.

Science and engineering ethics·2014
Same journal

GLP-1 Receptor Agonist Therapy in Children and Adolescents with Obesity: A Network Meta-Analysis of Differential Cardiometabolic Efficacy and Safety Profiles.

Pharmacological research·2026
Same journal

Sinomenine regulates the AKT/FOXO3/GLUL pathway to inhibit pulmonary fibroblast-to-myofibroblast transition via α7nAChR against rheumatoid arthritis associated interstitial lung disease.

Pharmacological research·2026
Same journal

Ketohexokinase: A central mediator of fructose-associated pathogenesis and promising therapeutic target.

Pharmacological research·2026
Same journal

GLP-1-based combination strategies for weight loss: Multi-target agents and combination therapies.

Pharmacological research·2026
Same journal

Cajaninstilbene acid in macrophage immunometabolism and angiogenesis: Mechanisms and therapeutic potential.

Pharmacological research·2026
Same journal

From Mechanisms to Therapy: Targeting the Gut-Brain Axis in Chronic Gastrointestinal Pain.

Pharmacological research·2026
See all related articles

Pharmacogenetics uses human genetic variance to tailor drug therapies for improved safety and efficacy. This field promises personalized medicine while presenting new ethical considerations in research and clinical practice.

Area of Science:

  • Pharmacogenetics
  • Genomics
  • Drug Development

Background:

  • Genetic variations significantly impact individual responses to medications.
  • Current drug development and clinical practice do not fully account for pharmacogenetic differences.

Purpose of the Study:

  • To explore the impact of human genetic variance on drug response.
  • To discuss the implications of pharmacogenetics for drug development and clinical practice.
  • To examine the ethical challenges posed by pharmacogenetics.

Main Methods:

  • Review of existing literature on pharmacogenetics.
  • Analysis of the influence of genetic variability on therapeutic outcomes.
  • Discussion of ethical frameworks relevant to pharmacogenetic research and application.
Keywords:
Biomedical and Behavioral ResearchGenetics and Reproduction

Related Experiment Videos

Main Results:

  • Pharmacogenetics enables safer, more effective drug therapies.
  • Genetic variance influences clinical trial outcomes and product use.
  • New ethical challenges arise in pharmacogenetic research and therapy.

Conclusions:

  • Pharmacogenetics is key to achieving individualized medicine.
  • The integration of pharmacogenetics will transform drug development and patient care.
  • Addressing ethical considerations is crucial for the advancement of pharmacogenetics.